---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-082566"
form_type: "8-K"
ticker: "REPL"
cik: "0001737953"
company_name: "Replimune Group, Inc."
filed_at: "2023-07-20T23:59:59+00:00"
generated_at: "2026-06-13T05:40:54.356160+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Sander Slootweg to leave Replimune board at 2023 annual meeting

## Summary
- Sander Slootweg, founder/managing partner at Forbion, will not stand for reelection at the upcoming annual meeting.
- Departure is not due to any dispute or disagreement with Replimune or its management.
- Slootweg served as non-executive director since company's inception; CEO expresses gratitude for his service.

## SEC filing metadata
- accession: 0001104659-23-082566
- form_type: 8-K
- ticker: REPL
- cik: 0001737953
- company_name: Replimune Group, Inc.
- filed_at: 2023-07-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737953/000110465923082566/0001104659-23-082566-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737953/000110465923082566/tm2321618d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-082566
- JSON: https://secwatch.observer/filing/0001104659-23-082566.json
- Plain text: https://secwatch.observer/filing/0001104659-23-082566.txt

## Key facts
- Executive change
  Sander Slootweg departed as Director at Replimune Group, Inc..
  - Action: will not stand for reelection
  - Role: Director
  source text: On July 14, 2023, Sander Slootweg, a member of the Board of Directors (the “Board”) of Replimune Group, Inc. (the “Company”), notified the Board that he will not stand for reelection at the Company’s 2023 annual meeting of stockholders (the “Annual Meeting”), and therefore his service as a director of the Company will end at the conclusion of the Annual Meeting.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1737953/000110465923082566/0001104659-23-082566-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.